Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Drug: Placebo (ZP8396)
DRUG
2 trials
Sponsors
Zealand Pharma
, Neuroventi Inc.
Conditions
Autism Spectrum Disorder (ASD
Healthy Volunteers
Obese
Overweight
Phase 1
A Research Study Looking at the Safety of Multiple Doses of ZP8396 and How it Works in the Body of Healthy Participants
Completed
NCT05613387
Zealand Pharma
Healthy Volunteers, Obese, Overweight
Start: 2022-11-07
End: 2024-06-13
Updated: 2024-06-18
Phase 2
Phase II Clinical Trial to Evaluate the Efficacy and Safety of NV01-A02 in Children With Autism Spectrum Disorder
Recruiting
NCT06951854
Neuroventi Inc.
Autism Spectrum Disorder (ASD
Start: 2025-04-01
End: 2026-12-01
Target: 105
Updated: 2025-04-30
Related Papers
2598-P: Long-Acting Amylin Analog Petrelintide Does Not Delay Gastric Emptying
Diabetes
2026-06-05